MedTrace Logo

Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents

NCT03276221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2024-02-01

Study results available
· View outcomes & findings →

Summary

This study will use a randomized controlled design to test whether 30 days of cannabis abstinence, compared to 30 days of monitoring, is associated with improvements in cognitive functioning. Non-using controls will also be enrolled to determine the clinical significance of any cognitive improvements with abstinence.

Conditions

  • Cannabis Use
  • Cognitive Change
  • Adolescent Behavior

Interventions

BEHAVIORAL

Abstinence

Cannabis users randomized to this condition will be enrolled in a contingency management intervention for 30 days of cannabis abstinence.

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Randi M Schuster, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2022-11-09
Completion
2022-11-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276221 on ClinicalTrials.gov